Signaling pathways of chronic kidney diseases, implications for therapeutics

Q Yuan, B Tang, C Zhang - Signal transduction and targeted therapy, 2022 - nature.com
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …

Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review

EGE Elsakka, MM Mokhtar, M Hegazy, A Ismail… - Life Sciences, 2022 - Elsevier
The endocytosis mechanism is a complicated system that is essential for cell signaling and
survival. Megalin, a membrane-associated endocytic receptor, and its related proteins such …

[HTML][HTML] KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease

Y Mori, AK Ajay, JH Chang, S Mou, H Zhao, S Kishi… - Cell metabolism, 2021 - cell.com
Tubulointerstitial abnormalities are predictive of the progression of diabetic kidney disease
(DKD), and their targeting may be an effective means for prevention. Proximal tubular (PT) …

High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction

Y Sun, X Ge, X Li, J He, X Wei, J Du, J Sun, X Li… - Cell death & …, 2020 - nature.com
Obesity has been recognized as a major risk factor for chronic kidney disease, but the
underlying mechanism remains elusive. Here, we investigated the mechanism whereby long …

The PI3K/Akt pathway in meta-inflammation

M Acosta-Martinez, MZ Cabail - International journal of molecular …, 2022 - mdpi.com
Obesity is a global epidemic representing a serious public health burden as it is a major risk
factor for the development of cardiovascular disease, stroke and all-cause mortality. Chronic …

Lipid accumulation and chronic kidney disease

Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu… - Nutrients, 2019 - mdpi.com
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic
kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is …

Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations

H Noels, M Lehrke, R Vanholder… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) induces modifications in lipid and lipoprotein metabolism and
homeostasis. These modifications can promote, modulate and/or accelerate CKD and …

Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential

D Yang, MJ Livingston, Z Liu, G Dong, M Zhang… - Cellular and Molecular …, 2018 - Springer
Diabetic kidney disease, a leading cause of end-stage renal disease, has become a serious
public health problem worldwide and lacks effective therapies. Autophagy is a highly …

Lysosomal storage disorders–challenges, concepts and avenues for therapy: beyond rare diseases

ARA Marques, P Saftig - Journal of cell science, 2019 - journals.biologists.com
The pivotal role of lysosomes in cellular processes is increasingly appreciated. An
understanding of the balanced interplay between the activity of acidic hydrolases, lysosomal …

Targeting inflammation in diabetic nephropathy: a tale of hope

JA Moreno, C Gomez-Guerrero, S Mas… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Diabetic nephropathy (DN) is the leading cause of chronic kidney disease
(CKD) and end-stage renal disease (ESRD). Beyond the new anti-diabetic drugs that …